121 related articles for article (PubMed ID: 12527520)
1. [Magnetic resonance imaging enhanced by superparamagnetic iron oxide particles in detecting lymph node metastasis of tumors: an experimental study].
Wu YK; Xu YK; Zhang JN; Wu FL; Liu XY; Huang QL
Di Yi Jun Yi Da Xue Xue Bao; 2003 Jan; 23(1):62-4. PubMed ID: 12527520
[TBL] [Abstract][Full Text] [Related]
2. [Superparamagnetic iron oxide-enhanced magnetic resonance imaging of hepatocellular carcinoma in rats].
Liu X; Xu YK; Huang QL; Wu YK
Di Yi Jun Yi Da Xue Xue Bao; 2002 Dec; 22(12):1061-5. PubMed ID: 12480574
[TBL] [Abstract][Full Text] [Related]
3. MR lymphography with iron oxide particles: dose-response studies and pulse sequence optimization in rabbits.
Hamm B; Taupitz M; Hussmann P; Wagner S; Wolf KJ
AJR Am J Roentgenol; 1992 Jan; 158(1):183-90. PubMed ID: 1727343
[TBL] [Abstract][Full Text] [Related]
4. Interstitial MR lymphography with iron oxide particles: results in tumor-free and VX2 tumor-bearing rabbits.
Taupitz M; Wagner S; Hamm B; Binder A; Pfefferer D
AJR Am J Roentgenol; 1993 Jul; 161(1):193-200. PubMed ID: 8517301
[TBL] [Abstract][Full Text] [Related]
5. [Lymph node image with ultrasmall superparamagnetic iron oxide and comparison with pathological result].
Xue HD; Lei J; Li Z; Wang DT; Zhou WX; Dai W; Jin ZY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Apr; 31(2):139-45. PubMed ID: 19507589
[TBL] [Abstract][Full Text] [Related]
6. [MR diagnosis for metastasis or non-metastasis of mediastinal and hilar lymph nodes in cases of primary lung cancer: detectability, signal intensity, and MR-pathologic correlation].
Fujimoto K; Edamitsu O; Meno S; Abe T; Honda N; Ogoh Y; Ohzono H; Nakaoda K; Kojima K; Nishimura H
Nihon Igaku Hoshasen Gakkai Zasshi; 1995 Feb; 55(3):162-71. PubMed ID: 7731772
[TBL] [Abstract][Full Text] [Related]
7. Experimental lymph node metastases: enhanced detection with MR lymphography.
Weissleder R; Elizondo G; Josephson L; Compton CC; Fretz CJ; Stark DD; Ferrucci JT
Radiology; 1989 Jun; 171(3):835-9. PubMed ID: 2717761
[TBL] [Abstract][Full Text] [Related]
8. [Experimental study of VX2 rabbits metastatic and inflammatory adenopathy by using dynamic contrast-enhanced MR imaging].
Zhang WD; Li CX; Luo RG; Wu PH
Zhonghua Yi Xue Za Zhi; 2012 Mar; 92(9):596-9. PubMed ID: 22800946
[TBL] [Abstract][Full Text] [Related]
9. The efficacy of MRI with ultrasmall superparamagnetic iron oxide particles (USPIO) in head and neck cancers.
Baghi M; Mack MG; Hambek M; Rieger J; Vogl T; Gstoettner W; Knecht R
Anticancer Res; 2005; 25(5):3665-70. PubMed ID: 16101198
[TBL] [Abstract][Full Text] [Related]
10. Mediastinal lymph nodes in patients with non-small cell lung cancer: preliminary experience with diffusion-weighted MR imaging.
Hasegawa I; Boiselle PM; Kuwabara K; Sawafuji M; Sugiura H
J Thorac Imaging; 2008 Aug; 23(3):157-61. PubMed ID: 18728541
[TBL] [Abstract][Full Text] [Related]
11. MR lymphography using iron oxide particles. Detection of lymph node metastases in the VX2 rabbit tumor model.
Taupitz M; Wagner S; Hamm B; Dienemann D; Lawaczeck R; Wolf KJ
Acta Radiol; 1993 Jan; 34(1):10-5. PubMed ID: 8427741
[TBL] [Abstract][Full Text] [Related]
12. Ex vivo MRI of axillary lymph nodes in breast cancer.
Luciani A; Pigneur F; Ghozali F; Dao TH; Cunin P; Meyblum E; De Baecque-Fontaine C; Alamdari A; Maison P; Deux JF; Lagrange JL; Lantieri L; Rahmouni A
Eur J Radiol; 2009 Jan; 69(1):59-66. PubMed ID: 19112002
[TBL] [Abstract][Full Text] [Related]
13. Discrimination of benign and malignant lymph nodes at 7.0T compared to 1.5T magnetic resonance imaging using ultrasmall particles of iron oxide: a feasibility preclinical study.
Kinner S; Maderwald S; Albert J; Parohl N; Corot C; Robert P; Baba HA; Barkhausen J
Acad Radiol; 2013 Dec; 20(12):1604-9. PubMed ID: 24200489
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance lymphography in rats: effects of muscular activity and hyperthermia on the lymph node uptake of intravenously injected superparamagnetic iron oxide particles.
Elste V; Wagner S; Taupitz M; Pfefferer D; Kresse M; Hamm B; Berg R; Wolf KJ; Semmler W
Acad Radiol; 1996 Aug; 3(8):660-6. PubMed ID: 8796730
[TBL] [Abstract][Full Text] [Related]
15. [A preliminary study on MR lymphography with iron chondroitin sulfate colloid].
Okuhata Y; Urahashi S; Kamata R; Arimizu N
Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Jun; 50(6):671-3. PubMed ID: 2122415
[TBL] [Abstract][Full Text] [Related]
16. Optimization of ultrasmall superparamagnetic iron oxide (P904)-enhanced magnetic resonance imaging of lymph nodes: initial experience in a mouse model.
Yoo RE; Cho HR; Choi SH; Won JK; Kim JH; Sohn CH
Anticancer Res; 2014 Oct; 34(10):5389-96. PubMed ID: 25275033
[TBL] [Abstract][Full Text] [Related]
17. Comparison of two different iron oxide-based contrast agents for discrimination of benign and malignant lymph nodes.
Kinner S; Maderwald S; Albert J; Parohl N; Corot C; Robert P; Baba HA; Barkhausen J
Invest Radiol; 2012 Sep; 47(9):511-5. PubMed ID: 22864375
[TBL] [Abstract][Full Text] [Related]
18. [Clinical significance of diffusion-weighted MRI with STIR-EPI in differential diagnosis of cervical lymph nodes].
Zhang Y; Liang BL; Gao L; Zhong JL; Ye RX; Shen J
Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):70-3. PubMed ID: 17575700
[TBL] [Abstract][Full Text] [Related]
19. Relationship between contrast enhancement on fluid-attenuated inversion recovery MR sequences and signal intensity on T2-weighted MR images: visual evaluation of brain tumors.
Kubota T; Yamada K; Kizu O; Hirota T; Ito H; Ishihara K; Nishimura T
J Magn Reson Imaging; 2005 Jun; 21(6):694-700. PubMed ID: 15906343
[TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance imaging diagnosis of metastatic lymph nodes in a rabbit model: efficacy of PJY10, a new ultrasmall superparamagnetic iron oxide agent, with monodisperse iron oxide core and multiple-interaction ligands.
Yoo RE; Choi SH; Cho HR; Jeon BS; Kwon E; Kim EG; Park J; Myeong WJ; Won JK; Lee YS; Kim JH; Park SW; Sohn CH
PLoS One; 2014; 9(9):e107583. PubMed ID: 25216040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]